Singapore: European Forum Against Blindness (EFAB) has revealed the results of a six-country study which analyzed the ec...
Singapore: Gilead Sciences has submitted a New Drug Application (NDA) to the US FDA for approval of sofosbuvir, a once-d...
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...
Bangalore: Advinus Therapeutics, a Bangalore-based drug discovery and development company, and P2D Bioscience, a CNS-foc...
What is Glivec?Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, ...
Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generall...
Singapore: Israel-based Sol-Gel Technologies achieved positive results for a phase II trial in the US targeting mild-to-...
Singapore: The Indian Ministry of Health and Family Welfare has notified the draft rules on a new domain of medicines ca...
Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...
Singapore: The US FDA has cancelled an advisory committee meeting that was scheduled to be held on July 18, 2013, in ord...
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...
Singapore: Agilent Technologies and US-based SomaLogic have entered into an agreement to expand access to SomaLogic's un...
Singapore: Boehringer Ingelheim and Eli Lilly and Company received approved from the US FDA for a supplemental new drug ...
Singapore: Regeneron Pharmaceuticals and Sanofi have been asked by the US FDA to assess potential neurocognitive side ef...
Singapore: Taiwan-based TWi Biotechnology has received notification of patent allowance for AC-201, its lead drug candid...
Singapore: Nasopharyngeal carcinoma (NPC) is a rare form of cancer in Western Europe and North America and is emerging a...
Singapore: A clinical drug for Huntington's and Alzheimer's disease by Australia-based Prana Biotechnology, a global dev...
Singapore: Despite concerns around declines in R&D, there would be a surge in global sales in the coming years reach...
